China Resources Double-Crane Pharmaceutical Co.,Ltd.

シンボルマーク: 600062.SS

SHH

23.35

CNY

今日の市場価格

17.5971
PER（株価収益率
-0.5329
PEGレシオ
24.20B
MRK キャップ
0.01%
DIV利回り

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062-SS) 財務諸表

Q: 企業のフリーキャッシュフローとは？

フリーキャッシュフローは .

Download

年次四半期

リニア対数

チャート上ではのダイナミクスにおけるデフォルトの数値を見ることができる。China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS). 会社の収益は NaN M の平均を示し、これは NaN % の成長率です。全期間の平均売上総利益は NaN M であり、NaN % である。平均売上総利益率は NaN % である。昨年度の純利益成長率はNaN % で, NaN % % に等しい。に等しい.,

年次四半期

10Y 20Y 30Y 40Y

貸借対照表

China Resources Double-Crane Pharmaceutical Co.,Ltd.の財政の軌跡に飛び込むと、平均的な資産の伸びが観察される。この率は、興味深いことに、であり、会社の最高と最低の両方を反映している。前期比で比較すると、この数字はに調整される。過去1年間を振り返ってみると、総資産の変動は NaN となる. 総株主資本によって示される株主価値は、報告通貨でのNaN で評価される。この面の前年比変化はNaN% である.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	3457	2830.7	3637.6	3262.2	2602.1	1975.7	1248.1	1486.9	778.2	1366.3	1410	1004.7	1104.5	1056.6	1023.5	1028.4	654.3	452	668.7	573.7	444.7	513.7	555.3	302.8	318.7	140.7	337.9	9.2	14.3	1.1
balance-sheet.row.short-term-investments	240.7	200.5	803.6	851.9	758.1	878.7	-18	-33.2	-42.6	-31.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	98.4	0	0	0	0	0	0
balance-sheet.row.net-receivables	2403.5	2362.8	2127	2216.7	2130.9	2017.5	1892.7	1864.7	1737.4	1386.6	1886.8	1969.7	1849.3	1408.8	1239.8	1012.2	1358.8	971.1	1095.3	1209.3	1378.7	1197.8	720.6	44.7	37.8	39.6	86.3	23.4	67.9	76.3
balance-sheet.row.inventory	1562.4	1878.6	1665.5	1289.3	1146	973.6	974.2	762.8	808.7	653.7	566.1	779.1	701	709.9	600.1	604.5	528.6	466.5	507.3	485.2	563.6	584.7	407.4	174.5	141.5	117.3	30.2	36.5	0	1.8
balance-sheet.row.other-current-assets	215.5	92.8	92.5	32	159.7	168.4	665.1	191.4	435	514.4	18.2	138	42.2	18.2	6.2	37.3	-231	-69.9	-137.1	-129.7	-72.7	-115	0.5	294.9	210.2	79.3	-26.2	-8.3	-3.2	-2.9
balance-sheet.row.total-current-assets	7638.5	7165	7522.6	6800.3	6038.7	5135.2	4780.2	4305.8	3759.3	3921.1	3881.2	3891.6	3697	3193.5	2869.6	2682.5	2310.6	1819.6	2134.1	2138.5	2314.2	2181.2	1683.8	816.9	708.3	376.9	428.2	60.8	79	76.3
balance-sheet.row.property-plant-equipment-net	3852.5	3506.6	2957.1	2673	2621.8	2632.5	2449.6	2361.4	2444.2	2053.6	2017.5	2027.8	1827.4	1563.2	1432.5	1223.9	997.8	1274.6	1504.9	1552.1	1538.7	1120.4	912.9	452.4	336.9	236	123.7	93.5	53.3	55
balance-sheet.row.goodwill	906.1	935	788.2	796.4	839.8	864.4	797	391.7	391.7	109.5	109.5	110.3	66.6	9.1	9.1	9.1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	2482.3	2281	1899.5	1650.7	1637.4	1525.6	1315.8	1031.9	978	385.4	384.7	343	307.9	233.1	201.7	147.8	163.6	52.2	53.3	74.9	78.5	75.9	45.2	60.3	61.6	67.5	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	3388.3	3216	2687.7	2447.1	2477.2	2390	2112.8	1423.6	1369.7	494.9	494.2	453.3	374.5	242.2	210.7	156.9	164.4	52.2	53.3	74.9	78.5	75.9	45.2	60.3	61.6	67.5	0	0	0	0
balance-sheet.row.long-term-investments	403.1	149.8	-500.2	-481.9	-723.9	-855.9	20.1	49.7	64.3	53	0	0	0	0	0	0	0	0	109.6	0	0	0	98.7	40.7	0	0	0	0	0	0
balance-sheet.row.tax-assets	192	124.7	73.8	52.2	50.3	53.5	50.2	42.8	29.2	27.7	29.9	21.7	23.6	27.2	27	24.6	14.3	0	0	0	0	0	5.7	111.5	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	22.1	320.6	935.1	925.7	812.7	951	24.9	58.3	96.5	68.9	58.1	113.5	154.4	179.4	177.1	181.2	186.3	112.9	11.4	259.7	326.4	239	0	2.4	78	60.6	22.8	0	0	0
balance-sheet.row.total-non-current-assets	7858	7317.6	6153.5	5616.2	5238.2	5171	4657.7	3935.8	4003.8	2698.2	2599.7	2616.2	2380	2012.1	1847.4	1586.6	1362.8	1439.7	1679.2	1886.7	1943.6	1435.3	1062.5	667.3	476.6	364.1	146.5	93.5	53.3	55
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	15496.5	14482.5	13676.1	12416.5	11276.9	10306.2	9437.9	8241.5	7763.1	6619.3	6480.9	6507.8	6077	5205.5	4717	4269	3673.5	3259.3	3813.3	4025.3	4257.9	3616.5	2746.3	1484.2	1184.8	741	574.7	154.3	132.3	131.3
balance-sheet.row.account-payables	696.7	744.5	847.4	848	690.8	547.3	469.2	395.7	400.7	488.4	428.5	959.9	718.3	568.3	518.1	440.5	593	624.2	745.1	924.6	1041.8	829.2	499.7	192.8	116.4	33.1	19.6	8.2	11.5	18
balance-sheet.row.short-term-debt	432.9	32.1	29.5	6.6	64.9	75	0	0	30	0	210	295	400.7	279.4	278	341.5	311	318.5	717.8	885.4	875.8	697.9	374.5	249.3	186.6	106	75	31.5	0.4	0
balance-sheet.row.tax-payables	65.7	201.7	138.9	122.6	131.3	153.6	113.9	108.7	121.4	68.2	112.3	62.9	150.7	68.7	55.7	60.9	120.3	65.2	101.4	113.6	94.6	131.3	84.9	69.9	41.2	21.3	2.4	-0.2	0	0
balance-sheet.row.long-term-debt-total	29.9	232.9	35.4	151	0.5	7	1.5	1.5	11.2	1.2	0	0	0	13.4	0	0	16	23	4.1	4.1	204	8.6	52	1	2.3	10	0	4	0	0
Deferred Revenue Non Current	180.6	198.8	153.8	100.9	97.8	113.8	108.2	111.4	132.7	108.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1822.3	2042.3	57.2	43.9	43.9	1352.2	739.9	619.6	120.4	337.9	89.6	65.9	59.6	52	43.8	29.3	68.8	31.4	55.8	38.1	43.6	49	32.1	18.2	35.7	0.7	0	2.6	3.5	18.4
balance-sheet.row.total-non-current-liabilities	364	741.1	468.6	369.5	258.9	269.6	380.2	187.8	224.9	108.6	115.8	118.7	81.8	89.5	54.1	41.3	52.2	29.9	52.4	65.5	264.7	45.9	106.3	6.7	7.2	11	0	4	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	29.9	32.9	35.4	121.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	3526.1	3752.9	3199.5	3039.5	2600.3	2397.6	1589.3	1203.1	1329.2	934.9	1144.7	1801	1733.7	1279.6	1182.2	1118.6	1308.8	1264.1	1874	2297.9	2541.2	2011.6	1256.3	628.9	473.6	199.6	101.8	48.5	29.2	36.4
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1039.7	1043.2	1043.2	1043.2	1043.2	1043.2	869.4	724.5	724.5	571.7	571.7	571.7	571.7	571.7	571.7	476.4	441.1	441.1	441.1	441.1	441.1	441.1	339.3	305.7	235.2	147	147	88	86.8	86.8
balance-sheet.row.retained-earnings	9670.6	8560.9	8196.4	7580.1	6892.1	6186.8	5517.4	4939.2	4374.9	3643.3	3296.9	2610.9	2216	1867.4	1511.8	1249.4	980.8	527	462.5	326.3	289	244.3	171.4	132.8	71.9	86.5	38	4.5	1.9	1.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	380	594.3	561.9	566.8	563.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	0	-175.7	103.9	103.9	103.9	609.9	1070	1022.5	1007.2	1464.1	1464.1	1471	1470	1424.1	1387.1	1353.7	775.6	847.5	824.3	771	761.7	718.8	772	352.1	385.2	300.5	287.9	13.3	14.4	6.2
balance-sheet.row.total-stockholders-equity	11090.4	10022.6	9905.5	9294.1	8602.5	7839.9	7456.8	6686.2	6106.7	5679.1	5332.7	4653.6	4257.7	3863.2	3470.5	3079.5	2197.5	1815.5	1727.9	1538.4	1491.8	1404.2	1282.8	790.6	692.2	534	472.9	105.8	103.1	94.9
balance-sheet.row.total-liabilities-and-stockholders-equity	15496.5	14482.5	13676.1	12416.5	11276.9	10306.2	9437.9	8241.5	7763.1	6619.3	6480.9	6507.8	6077	5205.5	4717	4269	3673.5	3259.3	3813.3	4025.3	4257.9	3616.5	2746.3	1484.2	1184.8	741	574.7	154.3	132.3	131.3
balance-sheet.row.minority-interest	699.4	707	571.1	82.9	74.1	68.7	391.8	352.3	327.2	5.2	3.5	53.1	85.6	62.8	64.3	70.9	167.2	179.7	211.4	188.9	224.8	200.7	207.2	64.7	19	7.5	0	0	0	0
balance-sheet.row.total-equity	11789.8	10729.6	10476.6	9377	8676.6	7908.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	643.8	350.3	303.4	370.1	34.3	22.8	2.1	16.5	21.7	21.6	26.7	26.7	64.1	85.3	83.4	81.5	82.9	103.4	109.7	252.2	325.6	194.5	98.7	139.1	70.1	53.2	0	0	0	0
balance-sheet.row.total-debt	462.9	265	64.9	6.6	64.9	82	0	0	41.2	1.2	210	295	400.7	292.8	278	341.5	311	318.5	721.9	889.5	1079.7	706.4	426.5	250.3	188.9	116	75	35.5	0.4	0
balance-sheet.row.net-debt	-2753.4	-2365.3	-2769.1	-2403.6	-1779.1	-1015.1	-1248.1	-1486.9	-737	-1365.1	-1200	-709.7	-703.8	-763.8	-745.5	-686.9	-343.3	-133.5	53.3	315.9	635	192.7	-128.8	45.9	-129.9	-24.7	-262.9	26.3	-13.9	-1.1

キャッシュフロー計算書

China Resources Double-Crane Pharmaceutical Co.,Ltd. の財務状況は、直近の期間においてフリー・キャッシュ・フローに顕著な変化が見られ、NaN の推移を示している。同社は最近、NaN を発行して株式資本を拡大し、前年度と比較してNaN の差を示した. 当社の投資活動は、報告通貨で NaN に相当する正味現金使用量をもたらしました。これは、NaN の前年からのシフトです. 同時期に、同社は NaN, NaN、および NaN を記録しており、同社の投資および返済戦略を理解する上で重要です. 財務活動によるキャッシュ・フローはNaN となり、前年同期との差はNaN となった。また、NaN を株主への配当に充当した。同時に、NaN と呼ばれるその他の財務操作も行っており、これらもこの期間のキャッシュフローに大きな影響を与えた. これらの要素を総合すると、会社の財務状況とキャッシュフロー管理に対する戦略的アプローチの包括的な絵が描かれる。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1333	1215.4	972.1	1013.5	1066.5	989.5	882.1	739.2	664.8	543.7	873.4	630.5	552.5	533	463.5	396.5	457.6	179.2	190	-25.4	51.6	146.2	162	138.6	75.3	61.1
cash-flows.row.depreciation-and-amortization	655.5	540.6	465	371.7	357.4	343.7	335.8	313.7	269.3	235.6	267.7	214.8	176.4	157.9	135.5	126.4	105.7	99.7	118.3	123.6	101.4	89.6	79.2	43.1	62.6	12.7
cash-flows.row.deferred-income-tax	-18.1	-20.7	-23.8	-3.1	-3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-1705.5	36	23.8	3.1	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-412.6	-413.5	-143.5	-62.4	-31.3	152.6	-35.3	-276.3	-213.7	-65.7	-368.2	-459.9	-244.8	-202.8	-214.2	-244.3	-197	-119.4	-227.4	103.3	-196.3	-145	-166.8	-26.1	-27.4	-93.2
cash-flows.row.account-receivables	-488.7	-266.2	-130.7	-216.2	-369.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	315.7	-34.3	-384.5	-146.8	-185.1	-4.9	-202.9	31.6	33.5	-85.2	-46.2	-78.1	18.8	-111.8	11.4	-104.9	-64.1	-14.1	-55	75.8	64.8	-58.4	-74.5	-33	-27.9	-87.1
cash-flows.row.account-payables	-221.6	-92.2	395.5	303.6	526.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-18	-20.7	-23.8	-3.1	-3.2	157.5	167.5	-307.9	-247.2	19.5	-321.9	-381.8	-263.6	-91.1	-225.6	-139.4	-133	-105.3	-172.4	27.5	-261.1	-86.6	-92.3	7	0.6	-6.1
cash-flows.row.other-non-cash-items	1798.5	-16.1	47.2	37.3	47.3	-16.8	4.5	-5.4	-19.1	4.7	-226.7	10.5	27.4	21.6	-42.7	53.2	-130.8	144.2	59	252.2	192.3	49.9	66.6	17.2	21.1	5.6
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-604.5	-525.5	-491.7	-348.1	-241.6	-228.7	-154.8	-110	-168.5	-142.4	-217.7	-221.9	-338.8	-370.2	-285.2	-309.2	-136.2	-171.7	-127.1	-196.8	-376	-252	-175.6	-86.8	-69.9	-130.3
cash-flows.row.acquisitions-net	-127.2	-409.2	36.6	42.7	-112.8	-257.7	-648.2	1.2	-697.1	149.4	194	-111.3	-50.3	0	0	0	171.8	41.6	12.8	0	43.5	2.2	4.8	0.2	0	0
cash-flows.row.purchases-of-investments	-2340	-1350	-3199.9	-2421.4	-3064.1	-2019.7	-1290.8	-735	-2607.5	-1280	-2.9	-4.6	-76.5	0	6.8	0	-24.1	-10.8	-15.7	0	-152.7	-55.7	-59.4	-169.3	-30	-26.8
cash-flows.row.sales-maturities-of-investments	2303	2951.7	3051.7	2296	2342.7	1678.7	864.9	1003	2723.7	898.6	119	94.9	55.8	0	2.8	1.2	2	45.4	261.6	11.7	4.5	2.1	103.7	5.7	1	0
cash-flows.row.other-investing-activites	60.9	-0.2	33.4	12.9	6.5	4	96.4	4.2	39.2	22	6.4	34.6	5.7	62.4	43.9	138.1	13	7.7	-21.9	32.7	7.8	-1.3	53.2	-2	0	12.9
cash-flows.row.net-cash-used-for-investing-activites	-707.8	666.8	-569.8	-418	-1069.3	-823.5	-1132.5	163.3	-710.1	-352.3	98.9	-208.3	-404.2	-307.8	-231.6	-170	26.6	-87.9	109.7	-152.4	-472.9	-304.7	-73.3	-252.2	-98.8	-144.2
cash-flows.row.debt-repayment	-9.3	-6.2	-47.7	-64.3	-306.9	-36.6	0	-40	-182.9	-210	-265	-694.8	-595.3	-283.8	-470.8	-350.3	-314.5	-689.3	-895.3	-983.1	-1113.8	-635.7	-576.7	-358.5	-224.9	-173.6
cash-flows.row.common-stock-issued	-29.7	144.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-1	-290.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-300.5	-801.8	-302.6	-319.3	-299.2	-91.1	-193.7	-184.7	-3.4	-199.7	-217.2	-250.8	-155	-145.7	-79.9	-111.3	-93.2	-106.4	-43.9	-48.1	-89.1	-68	-56.2	-41.6	0	-8.9
cash-flows.row.other-financing-activites	-17.8	-337	-28.3	-2.5	81.2	-675.4	-99.7	0	-397.7	0	371.5	613.4	694.5	275.5	386.4	723.7	304.6	392.3	775.9	858.8	1457.9	826.1	915.9	365.2	370.2	143.2
cash-flows.row.net-cash-used-provided-by-financing-activities	-358.3	-1291.2	-378.6	-386.2	-524.9	-803.1	-293.5	-224.7	-583.9	-409.7	-110.7	-332.3	-55.8	-154	-164.3	262.2	-103.1	-403.4	-163.3	-172.4	255	122.4	283.1	-34.9	145.3	-39.3
cash-flows.row.effect-of-forex-changes-on-cash	3.7	12.3	1.3	-0.1	0	0	-0.1	0	0.1	0	-0.4	-0.1	0.8	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	585.8	729.6	393.8	555.9	-154.4	-157.5	-238.9	709.9	-592.5	-43.7	534	-144.5	52.3	47.9	-53.9	423.9	159.1	-187.1	86.1	129	-69	-41.6	350.8	-114.3	178.1	-197.2
cash-flows.row.cash-at-end-of-period	3216.3	2614.7	1885.1	1491.3	935.4	1089.8	1247.3	1486.2	776.3	1366.3	1410	876	1020.6	968.2	920.3	974.2	550.3	375	562.1	573.7	444.7	513.7	555.3	204.5	318.7	140.7
cash-flows.row.cash-at-beginning-of-period	2630.4	1885.1	1491.3	935.4	1089.8	1247.3	1486.2	776.3	1368.8	1410	876	1020.6	968.3	920.3	974.2	550.3	391.2	562.1	476	444.7	513.7	555.3	204.5	318.7	140.7	337.9
cash-flows.row.operating-cash-flow	1650.8	1341.7	1340.9	1360.2	1439.8	1469	1187.1	771.2	701.3	718.4	546.2	396	511.5	509.7	342	331.7	235.5	303.7	139.8	453.7	148.9	140.6	141	172.8	131.5	-13.8
cash-flows.row.capital-expenditure	-604.5	-525.5	-491.7	-348.1	-241.6	-228.7	-154.8	-110	-168.5	-142.4	-217.7	-221.9	-338.8	-370.2	-285.2	-309.2	-136.2	-171.7	-127.1	-196.8	-376	-252	-175.6	-86.8	-69.9	-130.3
cash-flows.row.free-cash-flow	1046.3	816.1	849.2	1012.1	1198.1	1240.3	1032.3	661.2	532.9	576	328.6	174.2	172.7	139.5	56.9	22.5	99.3	132.1	12.6	256.9	-227	-111.4	-34.6	86	61.7	-144.1

損益計算書の行

China Resources Double-Crane Pharmaceutical Co.,Ltd. の売上は前期比 NaN% の変化。600062.SS の売上総利益は NaN と報告されている。同社の営業費用は NaN で、前期比NaN% の変化を示している. 減価償却費は NaN であり、前期からの増減率は NaN% である。営業費用は NaN と報告されており、前年比NaN% の変化を示している。販売・マーケティング費用は NaN で、前年度比 NaN% の変化である。直近の数字に基づくEBITDAは NaN で、前年比NaN% の伸びを示す。営業利益は NaN で、前年度比NaN% の変化を示している。当期純利益の増減率は NaN%。前年度の当期純利益は NaN であった。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	10089.3	9446.9	9111.5	8503.9	9381	8225.1	6421.8	5494.8	5138.4	4281	6834.6	6989.3	6383.4	5366.8	5037.9	4951.5	4556.6	4049.1	4597.4	4195.7	4249.2	3686.3	2382.7	1168.3	723.2	350.7	236.3	208.4	168.1	156.7
income-statement-row.row.cost-of-revenue	4948.2	4231.8	4030	3145.2	3430.6	3014.4	2733.7	2576.5	2473.1	2206	4470	4661.5	4321.5	3424.9	3327.6	3417.7	3186.3	2902.8	3365.2	3085.9	3096.8	2544.8	1500.4	634	447.5	227.2	160.9	131.1	103.4	107
income-statement-row.row.gross-profit	5141.2	5215.1	5081.5	5358.7	5950.3	5210.7	3688.1	2918.3	2665.3	2075	2364.6	2327.9	2061.9	1941.9	1710.4	1533.8	1370.4	1146.3	1232.3	1109.8	1152.4	1141.5	882.2	534.4	275.6	123.4	75.4	77.3	64.7	49.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-14.5	639.7	612.8	682.9	589.3	-5.2	-6.4	69.3	49.5	27.5	33.3	33	62.5	31.4	22.9	18.6	180.9	48.6	-16.2	12.1	20.3	21.1	19.8	11.3	16.5	12.6	4.4	0	0	0.6
income-statement-row.row.operating-expenses	3684.5	3901.5	3978.5	4121.8	4645.2	4031.3	2612.3	2060.8	1918.6	1453.1	1561.8	1613.5	1412.5	1335.3	1163.9	1071.9	913.5	920.4	1017.2	996.7	972.3	932.6	684.3	355.9	173.9	54.6	27.6	23.7	16.7	14.1
income-statement-row.row.cost-and-expenses	8632.6	8133.4	8008.5	7267	8075.8	7045.7	5346.1	4637.3	4391.8	3659	6031.7	6275	5734	4760.2	4491.5	4489.6	4099.7	3823.1	4382.3	4082.6	4069.1	3477.4	2184.7	989.9	621.4	281.8	188.5	154.8	120.1	14.1
income-statement-row.row.interest-income	52.9	88.5	54.4	48.5	20.3	12	10.9	9.7	26.8	24.4	16.8	12.8	12.2	5.8	5.1	0	0	7.7	15	4.8	5.3	9	3.8	3	0	0	0	0	0	0
income-statement-row.row.interest-expense	15.4	10.6	11.6	3.7	9.5	8.2	0	2.4	6.5	4.7	22.5	24.2	23.5	12.5	14.5	12.8	11.4	27	49.4	46.8	48.4	37.3	28.2	18.1	12	-3.5	-0.8	3	3.8	3.9
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	97.3	8.5	-15.8	-14.2	-0.7	4.8	-21.8	49.3	60.1	36.5	263.9	48.4	53.6	10.3	15	8.8	117.8	9.5	12.4	-99.2	-104.7	-27	-20	-6	-2.2	14.5	5.1	-3	-3.8	-3.9
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-14.5	639.7	612.8	682.9	589.3	-5.2	-6.4	69.3	49.5	27.5	33.3	33	62.5	31.4	22.9	18.6	180.9	48.6	-16.2	12.1	20.3	21.1	19.8	11.3	16.5	12.6	4.4	0	0	0.6
income-statement-row.row.total-operating-expenses	97.3	8.5	-15.8	-14.2	-0.7	4.8	-21.8	49.3	60.1	36.5	263.9	48.4	53.6	10.3	15	8.8	117.8	9.5	12.4	-99.2	-104.7	-27	-20	-6	-2.2	14.5	5.1	-3	-3.8	-3.9
income-statement-row.row.interest-expense	15.4	10.6	11.6	3.7	9.5	8.2	0	2.4	6.5	4.7	22.5	24.2	23.5	12.5	14.5	12.8	11.4	27	49.4	46.8	48.4	37.3	28.2	18.1	12	-3.5	-0.8	3	3.8	3.9
income-statement-row.row.depreciation-and-amortization	655.5	582.3	491	444.5	427.3	343.7	335.8	313.7	269.3	235.6	267.7	214.8	176.4	157.9	135.5	126.4	105.7	99.7	118.3	123.6	101.4	89.6	79.2	43.1	62.6	12.7	-1	3	3.8	-45.8
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1456.7	1406.1	1136.9	1229.3	1262.5	1189.3	1060.4	843.2	764.3	638.4	1033.9	731.3	655.2	592.7	542.2	452	393.8	222.1	270	29.9	116.7	208.2	189	175.1	93.2	73.5	48.9	50.7	44.2	31.7
income-statement-row.row.income-before-tax	1554	1414.6	1121.2	1215	1261.8	1184.1	1053.9	906.8	806.8	658.4	1066.8	762.8	703	616.9	561.4	470.7	574.7	253.1	240.7	28	106.2	205.6	193.4	179.4	104.6	84.7	53.1	50.7	44.2	31.7
income-statement-row.row.income-tax-expense	240.6	199.3	149.1	201.5	195.3	194.7	171.8	167.5	141.9	114.7	193.3	132.2	150.5	83.9	98	74.2	117.1	67.5	51.9	53.4	54.7	59.4	31.3	40.8	29.4	23.6	5.5	-3	0.2	0.2
income-statement-row.row.net-income	1333	1180.1	935.7	1005.2	1055.1	968.6	842.6	714.2	661.1	541.9	870.7	614.4	529	520.1	451.5	380.6	437.6	164.9	186.6	4.7	64.6	168.4	157.7	128.9	75.9	60.9	47.5	50.7	44	31.5